CEO of Successful Strategies for Life Sciences & CEO of The Beautiful Way.

Global Medical Evidence Generation Lead-Immunology, Sanofi

Board Chair & Executive Director Company, The Emily Whitehead Foundation

CEO, Managing Director and Chief Negotiator KMAK Capital

Co-founder Sugarloaf capital

Title: Managing Director

Organization: AKT Health Inc.

Andrew Hantel, MD, is a faculty member in the Divisions of Leukemia and Population Sciences at Dana-Farber Cancer Institute and the Harvard Medical School Center for Bioethics, and he is an Assistant Professor of Medicine at Harvard Medical School (HMS). He received his MD from Loyola University Chicago; trained in internal medicine, adult hematology/oncology, and medical ethics at the University of Chicago and in population sciences at the Dana-Farber/Harvard Cancer Center. Dr. Hantel’s clinical care focuses on patients with leukemia and related blood cancers; he also serves as a hospital ethics consultant. His research program leverages health services and care delivery methods to address ethical dilemmas in cancer discovery and delivery, for which he receives research funding from the National Institutes of Health, American Society for Clinical Oncology, American Cancer Society, and Greenwall Foundation. Dr. Hantel’s current work focuses on cancer health equity in the contexts of research participation, artificial intelligence, and climate change.

I am honored to join The Beautiful Way Foundation’s Scientific Advisory Board, as its mission aligns with my commitment to advancing health equity and improving access to ethical, inclusive cancer research. As a physician-scientist focused on cancer care delivery, my work seeks to address disparities in cancer discovery and care, ensuring that innovations in leukemia treatment and beyond are available to all communities.

The foundation’s dedication to bridging the gap between underrepresented populations and clinical research is critical to achieving meaningful progress in healthcare. My research on representative participation in cancer clinical trials has underscored the urgent need for inclusive, community-driven approaches to clinical research. By serving on this advisory board, I look forward to contributing my expertise in ethics, care delivery, and population sciences to help eliminate barriers, build trust, and create sustainable models for equitable healthcare.

Together, we have an opportunity to shape a future where healthcare innovation is representative, accessible, and just. I am excited to collaborate with The Beautiful Way Foundation to drive impactful solutions and meaningful change.

Bio: Jaynee Sasso, MBA, a visionary in senior care for two decades, founded LinkCo in 2017 to revolutionize healthcare. Combining personal experience with professional insight, she champions addressing social determinants of health for better outcomes. With a background as a caregiver and community influencer turned healthcare executive, she identifies and addresses systemic gaps. Her ethos of passion, trust, and integrity drives her mission to modernize outdated healthcare models. A respected speaker and leader, she guides organizations through transformative change, fostering community engagement and strategic partnerships with governmental and legislative bodies.

Reason I Joined Advisory Team: It was a great opportunity to support an organization whose mission is aligned with my company’s vision to create a more equitable and effective healthcare system that benefits patients, clinicians, and healthcare providers alike. I believe all stakeholders must rally around and support organizations like TBW to ensure the way in which healthcare is delivered and accessed takes into consideration all patient groups.